首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Development and validation of a scoring system to predict progression to acute‐on‐chronic liver failure in patients with acute exacerbation of chronic hepatitis B
【24h】

Development and validation of a scoring system to predict progression to acute‐on‐chronic liver failure in patients with acute exacerbation of chronic hepatitis B

机译:评分系统预测慢性乙型肝炎急性加剧患者急性慢性肝衰竭的进展的发展与验证

获取原文
获取原文并翻译 | 示例
           

摘要

Aim The aim of this study was to develop and validate a scoring system to predict the progression to acute‐on‐chronic liver failure (ACLF) in patients with acute exacerbation (AE) of chronic hepatitis B (CHB). Methods The baseline characteristics of 474 patients with AE of CHB were retrospectively reviewed; 280 and 194 patients were randomly assigned to the derivation and validation cohorts, respectively. Univariate risk factors associated with ACLF development were entered into a multivariate logistic regression. The score model was established, and its predictive value was evaluated by the receiver operating characteristic (ROC) curve and the area under the ROC curve (AUROC). Results Hepatitis B virus (HBV) DNA, international normalized ratio (INR) of prothrombin time, and patient age were identified as independent risk factors associated with progressing to ACLF. The prediction model was established as R?=??13.323?+?0.553?×?log HBV‐DNA (copies/mL)?+?3.631× INR?+?0.053?×?age. The AUROCs of our prediction model were higher than those of the Model for End‐stage Liver Disease (MELD) and MELD‐sodium (Na) for both cohorts. At the cut‐off value of ?2.43, our prediction model had higher sensitivity (87.5%), specificity (73.6%), positive predictive value (23.0%), positive likelihood ratio (3.30), and lower negative likelihood ratio (0.17) in the validation cohort than those of MELD and MELD‐Na. Conclusion The independent risk factors associated with progressing to ACLF in patients with AE of CHB are HBV‐DNA, INR, and age. Our risk prediction model is useful for predicting the development of ACLF.
机译:目的本研究的目的是开发和验证评分系统,以预测慢性乙型肝炎(CHB)急性加重(AE)患者对急性慢性肝功能衰竭(ACLF)的进展。方法回顾性审查474例CHB患者的基线特征; 280和194例分别随机分配给推导和验证队列。与ACLF开发相关的单变量危险因素进入多元逻辑回归。成立得分模型,其预测值由接收器操作特征(ROC)曲线和ROC曲线(AUROC)下的区域评估。结果乙型肝炎病毒(HBV)DNA,凝血酶原时间的国际标准化比(INR)和患者年龄的癌症因素被确定为与ACLF进行的独立危险因素。预测模型建立为r?= ?? 13.323?+?0.553?×α-α?log hbv-dna(拷贝/ ml)?+ 3.631×Inr?+ 0.053?×5岁。我们的预测模型的菌和对于两种侧面的终末期肝病(MELD)和含量(NA)的模型高。在截止值?2.43,我们的预测模型敏感性较高(87.5%),特异性(73.6%),阳性预测值(23.0%),阳性似然比(3.30),以及较低的负似然比(0.17)在验证队列比融合队和融合队伍中。结论AE CHB患者进展与ACLF相关的独立危险因素是HBV-DNA,INR和年龄。我们的风险预测模型可用于预测ACLF的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号